Can group support help young LGBTQ+ brazilians stick to HIV meds?

NCT ID NCT06056037

Recruiting now Disease control Sponsor: Brown University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a group-based support program to help young sexual and gender minority people (ages 18-24) in Rio de Janeiro take their HIV medication consistently. The program includes four sessions that focus on building social support, self-confidence, and problem-solving skills. The goal is to see if the program is feasible and acceptable, and whether it improves medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (group support sessions)
What this could lead to: If it works, this could point toward a low-cost, scalable way to improve HIV medication adherence among young sexual and gender minorities.
What could go wrong: This is a small pilot study (72 people) testing feasibility, not effectiveness. The results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHERENCE, MEDICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Coitus HIV infectious disease Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHERENCE, MEDICATION HIV

Contacts and locations

Locations

Evandro Chagas National Institute of Infectious Diseases (INI) Oswaldo Cruz Foundation (FIOCRUZ)
RECRUITING

Rio de Janeiro, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.